Ferro e Doença Hepática Alcoólica
DOI:
https://doi.org/10.24950/rspmi.880Palavras-chave:
Doença Hepática Alcoólica, Ferro/ metabolismo, Hepcidinas, Sobrecarga de FerroResumo
O complexo metabolismo do ferro à luz das recentes descobertas
dos mecanismos de regulação da sua absorção e distribuição
apresenta relação estreita com os mecanismos fisiopatológicos
da doença hepática alcoólica. Pretende-se fazer uma revisão
teórica dos mais recentes conceitos clínicos e moleculares, bem
como a relação entre o consumo de álcool com outras causas
conhecidas de sobrecarga de ferro.
Downloads
Referências
Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988;8:12-25.
McCullough AJ, O ́Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2022-2036.
Pequignot G, Cyrulnik F. Chronic disease due to overconsumption of alcoholic drinks (excepting neuropsychiatric pathology) in International Encyclopaedia of Pharmacology and Therapeutics, vol II. Oxford: Pergamon Press; 1970. p.375-412.
Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine. 1962; 41: 249-76.
Sorensen TI, Orholm M, Bentsen KD, Lancet, Høybye G, Eghøje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet. 1984; 2:241-4.
Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 1995; 346: 987-90.
Bellentani S, Saccoccio G, Costa G , Tiribelli C, Manenti F, Sodde M, et al. Drinking habits as cofators of risk for alcohol induced liver damage.
The Dionysos Study Group. Gut. 1997; 41: 845-50.
Sherlock S, Dooley J. Diseases of the Liver and Biliary System 11st ed. Oxford: Blackwell Publishing; 2002
Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci. 1975 Apr 25; 252:85-105.
Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health. 2003;27:209-19.
Becker U, Deis A, Sorensen TI, Grønbaek M, Borch-Johnsen K, Müller ,CF, et al. Prediction of risk of liver disease by alcohol, intake, sex, and
age: a prospective population study. Hepatology 1996; 23: 1025-1029.
Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004 Aug;24(3):217-32.
Corrao G, Ferrari P, Zambon A, Torchio P. Are the recent trends in liver cirrhosis mortality affected by the changes in alcohol consumption? Analysis of latency period in European countries. J Stud Alcohol 1997;58: 486-94.
MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis. 1986;6:221-232.
Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis. 2005;9:37-53.
Costa Matos L. Doença hepática alcoólica. Med-Interna, 2006, 2006;13:207-16.
John W. Adamson. Iron deficiency and other hypoproliferative anemias. In: Braunwald E, editor. Harrison´s Principles of Internal Medicine. 17th ed. New York: McGraw-Hill; 2008.
Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986-95.
Frazer DM, Anderson GJ. Iron imports. I. Intestinal iron absorption and its regulation. Am J Physiol Gastrointest Liver Physiol. 2005;289:G631-5.
Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World J
Gastroenterol. 2009;15:4617-26.
Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88:7-15.
Swanson CA. Iron intake and regulation: implications for iron deficiency and iron overload. Alcohol. 2003;30:99-102.
Brittenham GM, Weiss G, Brissot P, Lainé F, Guillygomarc’h A, Guyader D, et al. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Hematology Am Soc Hematol Educ Program. 2000:39-50.
Himmelfarb J. Iron regulation. J Am Soc Nephrol. 2007;18:379-81.
Collins JF, Wessling-Resnick M, Knutson MD. Hepcidin regulation of iron transport. J Nutr. 2008;138:2284-8.
Deugnier Y, Brissot P, Loréal O. Iron and the liver: update 2008. J Hepatol. 2008;48 Suppl 1:S113-23.
Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol. 2011;54:173-181.
Fletcher LM, Powell LW. Hemochromatosis and alcoholic liver disease. Alcohol. 2003;30:131-136.
Fletcher LM, Bridle KR, Crawford DH. Effect of alcohol on iron storage diseases of the liver. Best Pract Res Clin Gastroenterol. 2003;17:663-77.
Fletcher LM, Halliday JW, Powell LW. Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol Hepatol. 1999;14:202-14.
Pascoe A, Kerlin P, Steadman C, Clouston A, Jones D, Powell L, et al. Spur cell anaemia and hepatic iron stores in patients with alcoholic liver
disease undergoing orthotopic liver transplantation. Gut. 1999;45:301-5.
Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Hosoki Y, Saito H,et al. Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res. 2005;29(11
Suppl):189S-193S.
Sebastiani G, Walker AP. HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol. 2007 Sep 21;13:4673-89.
Eng SC, Taylor SL, Reyes V, Raaka S, Berger J, Kowdley KV. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron
deposition in other organs in the absence of HFE-1 hemochromatosis. Liver Int. 200;25:513-517.
Whitfield JB, Zhu G, Heath AC, Powell And LW, Martin NG. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res. 2001;25:1037-45.
Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med. 1994;236:315-322.
Machado MV, Gonçalves MS, Cortez-Pinto H. Metabolismo do ferro em alcoólicos crónicos em consumo activo e durante a abstinência. J Port Gastrenterol 2004, 11: 186-90.
Hearnshaw S, Thompson NP, McGill A. The epidemiology of hyperferritinaemia. World J Gastroenterol. 2006;12:5866-69.
Milman N, Ovesen L, Byg K, Graudal N. Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men
aged 40-70 years. Influence of blood donation, alcohol intake, and iron supplementation Ann. Hematol. 1999;78:393-400.
Ioannou GN, Dominitz JA, Weiss NS, Heagerty PJ, Kowdley KV. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology. 2004;126:1293-1301.
De Feo TM, Fargion S, Duca L, Cesana BM, Boncinelli L, Lozza P, et al. Non-transferrin-bound iron in alcohol abusers. Alcohol Clin Exp Res.
;25:1494-9.
Duane P, Raja KB, Simpson RJ, Peters TJ. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol. 1992;27:539-44.
Celada A, Rudolf H, Donath A. Effect of experimental chronic alcohol ingestion and folic acid deficiency on iron absorption. Blood. 1979;54:906-15.
Suzuki Y, Saito H, Suzuki M, Hosoki Y, Sakurai S, Fujimoto Y, et al. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res. 2002;26(8 Suppl):26S-31S
Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y, Kato J. Dysregulation of systemic iron metabolism in alcoholic liver diseases. J Gastroenterol Hepatol. 2008;23 Suppl 1:S78-81.
Harrison-Findik DD, Schafer D, Klein E, Timchenko NA, Kulaksiz H, Clemens D, et al. Alcohol metabolism-mediated oxidative stress down
-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem. 2006;281:22974-82.
Harrison-Findik DD, Klein E, Evans J, Gollan J. Regulation of liver hepcidin expression by alcohol in vivo does not involve Kupffer cell activation or TNF-alpha signaling. Am J Physiol Gastrointest Liver Physiol. 2009;296:G112-8.
Harrison-Findik DD. Role of alcohol in the regulation of iron metabolism. World J Gastroenterol. 2007;13:4925-30.
Heritage ML, Murphy TL, Bridle KR, Anderson GJ, Crawford DH, Fletcher LM. Hepcidin regulation in wild-type and Hfe knockout mice in response to alcohol consumption: evidence for an alcohol-induced hypoxic response. Alcohol Clin Exp Res. 2009;33:1391-1400.
Ohtake T, Saito H, Hosoki Y, Inoue M, Miyoshi S, Suzuki Y, et al. Hepcidin is down-regulated in alcohol loading. Alcohol Clin Exp Res. 2007;31(1 Suppl):S2-8.
Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ Res. 2005;97:967-74.
Swinkels DW, Drenth JP. Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction? J Hepatol.
;49(5):680-5.
Bridle K, Cheung TK, Murphy T, Walters M, Anderson G, Crawford DG, et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res.
;30:106-12.
Harrison-Findik DD, Klein E, Crist C, Evans J, Timchenko N, Gollan J. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology. 2007;46:1979-85.
Harrison-Findik DD. Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease? World J Gastroenterol. 2009;15:1186-93.
Iqbal T1, Diab A, Ward DG, Brookes MJ, Tselepis C, Murray J, et al. Is iron overload in alcohol-related cirrhosis mediated by hepcidin?World J
Gastroenterol. 2009;15:5864-6.
Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid fator in nonhemochromatotic liver disease. Alcohol. 2003;30:137-44.
Wallace DF, Subramaniam VN. Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron. Biochim Biophys
Acta. 2009;1790:663-70.
Flanagan JM, Peng H, Beutler E. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations. Alcohol Clin Exp Res. 2007;31:138-43.
Ropero Gradilla P, Villegas Martínez A, Fernández Arquero M, García-Agúndez JA, González Fernández FA, Benítez Rodríguez J, et al. C282Y
and H63D mutations of HFE gene in patients with advanced alcoholic liver disease. Rev Esp Enferm Dig. 2001;93:156-63.
Machado MV, Ravasco P, Martins A, Almeida MR, Camilo ME, Cortez-Pinto H. Iron homeostasis and H63D mutations in alcoholics with and
without liver disease. World J Gastroenterol. 2009;15:106-11.
Grove J1, Daly AK, Burt AD, Guzail M, James OF, Bassendine MF,et al. Heterozygotes for HFE mutations have no increased risk of advanced
alcoholic liver disease. Gut. 1998;43:262-6.
Gleeson D, Evans S, Bradley M, Jones J, Peck RJ, Dube A, et al. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls.
Am J Gastroenterol. 2006;101:304-10.
Lauret E, Rodríguez M, González S, Linares A, López-Vázquez A, Martínez-Borra J, et al. HFE gene mutations in alcoholic and virus-related
cirrhotic patients with hepatocellular carcinoma. Am J Gastroenterol. 2002;97:1016-21.
Frenzer A, Rudzki Z, Norton ID, Butler WJ, Roberts-Thomson IC. Heterozygosity of the haemochromatosis mutation, C282Y, does not
influence susceptibility to alcoholic cirrhosis. Scand J Gastroenterol. 1998;33:1324.
Robinson G, Narasimhan S, Weatherall M, Beasley R. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification. J Gastroenterol Hepatol. 2007;22:852-4.
Olynyk JK, Knuiman MW, Divitini ML, Bartholomew HC, Cullen DJ, Powell LW. Effects of HFE gene mutations and alcohol on iron status, liver biochemistry and morbidity. J Gastroenterol Hepatol. 2005;20:1435-41.
Raszeja-Wyszomirska J, Kurzawski G, Zawada I, Suchy J, Lubinski J, Milkiewicz P. HFE gene mutations in patients with alcoholic liver disease.
A prospective study from northwestern Poland. Pol Arch Med Wewn. 2010;120:127-31.
Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology.
;35:635-638.
Ganne-Carrié N, Christidis C, Chastang C, Ziol M, Chapel F, Imbert-Bismut F, et al. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study.Gut. 2000;46:277-82.
Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. World J Gastroenterol. 2007 21;13:4699-706.
Purohit V, Russo D, Salin M. Role of iron in alcoholic liver disease: introduction and summary of the symposium. Alcohol. 2003 ;30:93-7.
Deugnier Y, Turlin B, Loréal O. Iron and neoplasia. J Hepatol. 1998;28 Suppl 1:21-5.
Abalea V, Cillard J, Dubos MP, Anger JP, Cillard P, Morel I. Iron-induced oxidative DNA damage and its repair in primary rat hepatocyte culture. Carcinogenesis. 1998;19:1053-9.
Deugnier Y. Iron and liver cancer. Alcohol. 2003;30:145-50.
Troadec MB, Courselaud B, Détivaud L, Haziza-Pigeon C, Leroyer P, Brissot P, et al. Iron overload promotes Cyclin D1 expression and alters
cell cycle in mouse hepatocytes. J Hepatol. 2006;44:391-9.
Scotet V, Mérour MC, Mercier AY, Chanu B, Le Faou T, Raguénes O, et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol. 200315;158:129-34.
Fargion S, Fracanzani AL, Piperno A, Braga M, D’Alba R, Ronchi G, et al. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology. 1994;20:1426-31.
Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology. 1996;23:724-7.
Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology. 2002;122:281-9.
Pietrangelo A. Iron-induced oxidant stress in alcoholic liver fibrogenesis. Alcohol. 2003;30:121-9.
Tavill AS, Qadri AM. Alcohol and iron. Semin Liver Dis. 2004;24:317-25.
Tsukamoto H. Iron regulation of hepatic macrophage TNFalpha expression. Free Radic Biol Med. 2002;32:309-13.
Xiong S, She H, Sung CK, Tsukamoto H. Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol. 2003;30:107-13.
Tsukamoto H, Lin M, Ohata M, Giulivi C, French SW, Brittenham G. Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury. Am J Physiol. 1999;277(6 Pt 1):G1240-50.
Xiong S, She H, Tsukamoto H. Signaling role of iron in NF-kappa B activation in hepatic macrophages. Comp Hepatol. 2004;3 Suppl 1:S36.
Xiong S, She H, Zhang AS, Wang J, Mkrtchyan H, Dynnyk A, et al. Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2008;295:G512-21.
Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S, et al. Experimental liver cirrhosis induced by alcohol and iron. J
Clin Invest. 1995;96:620-30.
Bridle KR, Crawford DH, Ramm GA. Identification and characterization of the hepatic stellate cell transferrin receptor. Am J Pathol.
;162:1661-7.
Ramm GA, Britton RS, O’Neill R. Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes J Clin Invest.
;94:9-15.
Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol. 1997;26:584-92.
Darnis F, Mossé A, Breauté C, Delorme ML. Aspects actuels du traitement des hémochromatoses (à propos de 100 observations). Ann Med
Interne. 1971;122:1193-210.
Grace ND, Greenberg MS. Phlebotomy in the treatment of iron overload: a controlled trial (a preliminary report). Gastroenterology. 1971; 60, 744.
Powell LW: Changing concepts in haemochromatosis. Postgrad Med J. 1970;46:200-9.
Shaw S, Jayatilleke E. The role of cellular oxidases and catalytic iron in the pathogenesis of ethanol-induced liver injury. Life Sci. 1992;50:2045-52.
Otogawa K, Ogawa T, Shiga R et al. Attenuation of acute and chronic liver injury in rats by iron-deficient diet. Am J Physiol Regul Integr Comp Physiol. 2008;294:R311-20.
Kaji K, Yoshiji H, Kitade M et al. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1094-104.
Costa-Matos L, Batista P, Monteiro N et al. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Eur J Gastroenterol Hepatol. 2012;24:1158-65.
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2015 Medicina Interna
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
